Biogen Bets On Depression Drug In $1.5 Billion Deal With Sage Therapeutics

Biogen Inc will take a $650 million stake in Sage Therapeutics and make an upfront payment of $875 million to jointly develop and sell treatments for depression and other neurological disorders, the two companies said on Friday.

from Top Business News- News18.com